After the COVID 19 cases went up, despite the fact of the majority of the population being fully vaccinated, Indonesia decided to try the unimaginable – authorizing Ivermectin as a treatment for the virus.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
And, guess what happened?!
According to the report published by The Straits times,
“The Indonesian government on Thursday (July 15) began distributing free medicine and vitamins to self-isolating Covid-19 patients in high-risk areas as the highly transmissible Delta variant of the coronavirus continued to rip through the country, emptying pharmacy shelves.
Each package will have seven days worth of therapeutic Covid-19 drugs and vitamins, and will be given to asymptomatic patients as well as those with mild to moderate symptoms including fever and dry cough. The medication for the latter group will require consultation with a doctor and a prescription.
Medical facilities are stretched thin, and demand for oxygen and medication has also soared. As scores of people are isolating themselves at home and self-medicating, prices of drugs have shot up in pharmacies and online. The health ministry has since moved to cap the prices of drugs such as favipiravir, remdesivir, and ivermectin.”
Here’s more from Health Feedback.
“Clinical trials didn’t show a clear benefit of ivermectin in reducing COVID-19 severity, hospitalization rate, or mortality. Epidemiological evidence also doesn’t indicate that ivermectin helped curb the number of COVID-19 cases and deaths in Indonesia or in other countries. However, these countries implemented other measures that have proven effective in limiting the spread of the virus, including vaccination and restrictions, which likely contributed to the decline in COVID-19 cases.
Simply because two events coincide in time doesn’t necessarily mean that one caused the other. Firstly, ivermectin endorsement doesn’t tell us whether the Indonesian population actually used ivermectin more than populations in other countries.
Secondly, even if the use of ivermectin did increase following the recommendation, we still can’t assess whether the drop in COVID-19 cases in Indonesia was due to the use of ivermectin or to other factors. Epidemiological data from countries that recommended ivermectin, such as India and Peru, doesn’t indicate that promoting the drug reduced the spread of the disease or its death toll. Both countries experienced multiple COVID-19 waves with high mortality throughout 2020 and 2021, and both withdrew ivermectin recommendations in 2021.”
Wait, so we can’t use Ivermectin because “We don’t have enough data,”
“Let’s vaccinate children to see how safe the vaccine is because we don’t have enough data.”
Did I understand that correctly?
— Dr. Doug Corrigan (@ScienceWDrDoug) October 28, 2021
Do you believe it now?!